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Background: Isoferulic acid (IFA), a naturally occurring cinnamic acid derivative, is a main active ingredient of the
rhizoma of Cimicifuga dahurica. It has been shown various pharmacological activities. The aim of the study was to
investigate the effect of IFA against MG-induced protein glycation and oxidative DNA damage. Free radical
scavenging activity and the MGO-trapping abilities of IFA were also investigated.
Methods: The fluorescent MG-derived AGEs and non-fluorescent Nε-(carboxymethyl) lysine (Nε-CML) was measured
using a spectrofluorometer and an enzyme linked immunosorbant assay (ELISA). Protein carbonyl content was used
to detect protein oxidation. Gel electrophoresis was used to determine DNA damage. Superoxide anion radicals
and hydroxyl radicals were determined using cytochrome c reduction assay and thiobarbituric acid reactive
2-deoxy-D-ribose oxidation products, respectively. The MG-trapping capacity was performed by HPLC.
Results: IFA (1.25–5 mM) inhibited the formation of fluorescent MG-derived AGEs, and Nε-CML, and protein
carbonyl in bovine serum albumin. In addition, IFA (0.1–1 mM) also prevented MG/lysine-mediated oxidative
DNA damage in the presence and absence of copper ion. The protective ability of IFA was directly correlated to
inhibition of hydroxyl and superoxide anion radical generation during the reaction of MG and lysine. Most notably,
IFA had no the directly trapping ability to MG.
Conclusions: The present results highlighted that free radical scavenging activity, but not the MG-trapping ability,
is the mechanism of IFA for preventing MG-induced protein glycation and DNA damage.
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Methylglyoxal (MG), a highly reactive α-oxalaldehyde me-
tabolite, is formed endogenously during glucose, protein
and fatty acid metabolism. Other sources of MG, which
are formed during industrial processing and long-term
storage, are in sugar-containing foods and beverages, such
as bread, coffee, honey, wine, and beer [1]. Increased MG
levels are possible causal factors for development and pro-
gression of diabetes and its complications [2]. MG readily* Correspondence: Sirichai.a@chula.ac.th
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duce non-enzymatic protein glycation and subsequent
formation of advanced glycation end-products (AGEs),
crosslinks like methylglyoxal-lysine dimers, and Nε-(car-
boxymethyl) lysine (Nε-CML) [3]. The consequences of
these reactions alter the characteristics of proteins and
their physiochemical and biochemical properties. In vitro
experiments have recently shown that reactive oxygen
species (ROS) are also generated during the glycation
reaction of protein with MG. This results in depletion of
thiol-containing protein and an increase in protein car-
bonyl formation [4]. Besides direct glycation damage to
protein, MG reacting with lysine may contribute to oxi-
dative DNA damage, strand breakage and cell apoptosis
[5, 6]. Moreover, Cu2+ enhances MG-lysine mediatedicle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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produce hydroxyl radicals [7]. ROS-induced oxidative
DNA damage has been causally associated with the mech-
anism of mutagenesis [8]. In this regards, application of
AGE inhibitors has emerged as a new strategy to reduce
the occurrence of AGE-associated diseases. Recent atten-
tion has focused on identification of AGE inhibitors from
phytochemical compounds that act as antioxidants, che-
late metal ions, or directly trap MG [9].
Cinnamic acid and its derivatives are widely distributed
among fruits and vegetables in the human diet. They exert
many biological effects such as anti-inflammatory [10],
anti-oxidation [11], and anti-hyperglycemic activities [12].
Isoferulic acid (IFA), a naturally occurring cinnamic acid
derivative, is a main active ingredient of the rhizoma of
Cimicifuga dahurica [13], which targets multiple pathways
associated with antihyperglycemic activity. In vitro and
in vivo studies demonstrate that IFA has a plasma
glucose-lowering effect in streptozotocin-induced diabetic
rats [14]. The mechanism of its action involves activa-
tion of α1-adrenoceptors to enhance the secretion of
β-endorphin, which can stimulate the opioid μ-receptors
[15, 16]. The action leads to increased glucose utilization
and reduced hepatic gluconeogenesis. In addition, IFA is
the most inhibitor against intestinal α-glucosidase among
11 cinnamic acid derivatives [17]. Most interestingly,
IFA acts as an anti-glycating agent against fructose-
and glucose-induced protein glycation and oxidation-
dependent damage to protein [18]. However, no infor-
mation exists on the abilities of IFA to inhibit MG-
induced protein glycation and DNA damage.
The aim of the present work was to investigate the in-
hibitory effect of IFA on MG-induced protein glycation
and oxidative damage using bovine serum albumin
(BSA). Moreover, a glycation model system consisting of
lysine and MG together with Cu2+ was created to inves-
tigate the ability of IFA to prevent oxidative DNA dam-
age. Furthermore, IFA was evaluated for its free radical
scavenging activity in the model of lysine/MG and the
capacity in direct trapping of MG using HPLC.
Methods
Chemicals and reagents
Methylglyoxal (40 % in water), isoferulic acid (IFA, 3-
hydroxy-4-methoxycinnamic acid), bovine serum albu-
min (BSA, fraction V), aminoguanidine, 5,5’-dithiobis
(2-nitrobenzoic acid) (DTNB), 2-deoxy-D-ribose, 2-
methylquinoxaline, 5-methylquinoxaline, o-phenylene-
diamine, thiobarbituric acid and cupric sulfate (CuSO4)
were purchased from Sigma-Aldrich (St.Louis, MO, USA).
L-lysine, 2,4-dinitrophenyl hydrazine (DNPH) and guan-
idine hydrochloride were obtained from Himedia (Mumbai,
India), Ajax Finechem (Taren Point, Australia) and
Fluka (Steinheim, Germany), respectively. OxiSelect™Nε-(carboxymethyl) lysine (CML) ELISA kit was ac-
quired from Cell Biolabs (San Diego, CA, USA). QIA-
prep Spin Miniprep kit was obtained from Qiagen
(Venlo, Netherlands) and cytochrome c was purchased
from Affymetrix (Santa Clara, CA, USA). All other chemi-
cals used were of analytical grade.
Glycation of bovine serum albumin (BSA) by methylglyoxal
The glycated BSA formation assay was modified according
to a previously published method [19]. The reaction mix-
tures (1 mL per reaction) containing 460 μL of methyl-
glyoxal (MG, at final concentration of 1 mM), 500 μL of
20 mg/mL BSA (final concentration: 10 mg/mL) in 0.1 M
phosphate buffered saline (PBS, pH 7.4) and 40 μL of IFA
at various concentrations (final concentrations: 1.25, 2.5
and 5 mM) or aminoguanidine (AG, final concentration:
1.25 mM) were incubated at 37 °C for 2 weeks. All gly-
cated samples were taken for analysis of fluorescent MG-
derived AGEs, non-fluorescent Nε-CML, and carbonyl
content.
Measurement of fluorescent MG-derived AGEs
The fluorescent intensity was measured weekly to assess
MG-derived AGEs by using the excitation and emission
wavelengths at 355 and 460 nm, respectively. The inhibi-
tory effect of IFA on fluorescent MG-derived AGEs was
calculated as percentage inhibition following formula
below:
% Inhibition ¼ FC−FCBð Þ− FS−FSBð Þ
FC− FCB
 100
Where FC and FCB were the fluorescent intensity of
control with MG and blank of control without MG, FS
and FSB were the fluorescent intensity of IFA with MG
and blank of IFA without MG.
Measurement of non-fluorescent Nε-CML
Non-fluorescent Nε-(carboxymethyl) lysine (Nε-CML)
was measured using an enzyme linked immunosorbant
assay (ELISA) kit according to the manufacturer’s in-
struction. The absorbance of samples was measured im-
mediately at 450 nm and compared with the absorbance
of CML-BSA standard provided in the assay kit.
Determination of protein carbonyl content
The carbonyl content in glycated BSA was determined
according to a previously published method with slight
modifications [6]. Briefly, 10 mM DNPH in 2.5 M HCl
(400 μL) was added to 100 μL of glycated samples and
incubated for 1 h in the dark. Thereafter, 500 μL of 20 %
(w/v) trichloroacetic acid (TCA) was added to precipi-
tate protein for 5 min on ice and then centrifuged at
10,000 g for 10 min at 4 °C. The protein pellet was
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three times and resuspended in 250 μL of 6 M guanidine
hydrochloride. The absorbance was read at 370 nm. The
carbonyl content of each sample was calculated based
on the molar extinction coefficient for DNPH (ε =
22,000 M−1 cm−1) and final results were expressed as
nmol carbonyl/mg protein.
Plasmid extraction
The pUC19 plasmid was purified from competent
Escherichia coli by using QIAprep Spin Miniprep kit ac-
cording to the manufacturer’s protocol and measured
DNA concentration using the NanoDrop-1000 spectro-
photometer (Thermo Scientific, MA, USA). The plasmid
was kept at −20 °C until use.
DNA strand breakage
The assessment of DNA strand breakage was performed
according to a previous publication with minor modifi-
cations [7]. Extracted plasmid containing 0.25 μg DNA
was incubated with 2 μL of 250 mM lysine (final con-
centration: 50 mM), 2 μL of 250 mM MG (final concen-
tration: 50 mM), and 2 μL of IFA at various
concentrations (final concentration: 0.1, 0.25, 0.5 and
1 mM) with or without 1 μL of 3 mM CuSO4 (final con-
centration: 300 μM) in a total volume of 10 μL at 37 °C
for 3 h. The reaction was stopped at −20 °C for 90 min
before mixing with DNA loading dye and loading onto
0.8 % agarose gel in Tris-borate-EDTA (TBE) buffer.
The gel was electrophoresed at 80 V for 60 min, stained
with ethidium bromide and photographed by Gel Doc
imager (Syngene, UK). Plasmid DNA fragments detected
on agarose gel consisted of supercoiled form (SC) and
open circular form (OC). The intensity of each band was
analyzed using GeneTools software (Syngene, UK). The
results were expressed as the percentage of opened cir-
cular (% OC) calculated using the following formula be-
fore subtracting by % OC of untreated-DNA control.
%OC ¼ Intensity of OC
Intensity of OC þ SCð Þ  100
Determination of superoxide anion
Superoxide anion was determined by using cytochrome
c reduction assay with minor modifications [7]. The re-
action mixtures with equal volumes (200 μL) of 50 mM
lysine and 50 mM MG (final concentration: 10 mM)
with or without 100 μL of IFA (final concentrations: 0.1,
0.25, 0.5 and 1 mM) were adjusted to a total volume of
900 μL before adding 100 μL 300 μM cytochrome c
(final concentration: 30 μM) and monitoring the produc-
tion of superoxide anion by measuring reduced cyto-
chrome c at a wavelength of 550 nm every 10 min until180 min. The concentration of reduced cytochrome c at
each time point was calculated using its molar extinction
coefficient (27,700 M−1cm−1) and then subtracting base-
line (at 0 min). The results were expressed as nmol/mL.
Determination of hydroxyl radical
Hydroxyl radical was determined by measuring thiobar-
bituric acid reactive 2-deoxy-D-ribose oxidation prod-
ucts (TBARS) according to a previously published
method with minor modifications [7]. The reaction con-
tained equal volumes (20 μL) of 50 mM lysine, 50 mM
MG (final concentration: 10 mM) and 100 mM 2-deoxy-
D-ribose (final concentration: 20 mM) with or without
20 μL of IFA (final concentrations: 0.1, 0.25, 0.5 and
1 mM). The volume was adjusted to 100 μL using
10 mM PBS before incubating at 37 °C. After 3 h of in-
cubation, the mixture was added to an equal volume of
10 mM PBS (100 μL), 2.8 % (w/v) TCA and 1 % (w/v)
thiobarbituric acid (TBA), followed by heating at 100 °C
for 10 min, then cooling to room temperature. The deg-
radation of 2-deoxy-D-ribose was measured using a
spectrophotometer at a wavelength of 532 nm. The con-
centration of TBARS was calculated from malondialde-
hyde (MDA) standard and the results were expressed as
nmol/mL.
Determination of the MG-trapping capacity by HPLC
The MG-trapping capacity was done according to a pre-
viously published method with minor modifications [20].
A mixture of MG (1 mM) with IFA (1.25, 2.5 and
5 mM) or AG (1 mM) in phosphate buffer solution
(pH 7.4) at 37 °C was incubated for 1 h and 24 h. Quan-
tification of MG was based on the determination of its
derivative compound, 2-methylquinoxaline (2-MQ)
using HPLC with 5-methylquinoxaline (5-MQ) as the
internal standard. The solution containing 20 mM o-
phenylenediamine (o-PDA) (100 μL) and 5 mM 5-MQ
(100 μL) was added into the sample vials immediately
after MG/compound incubation. MG derivatization took
place at room temperature. After 30 min, the samples
were filtered prior to HPLC analysis. The remaining
non-derivatized MG in samples was quantified using
HPLC (Shimadzu Corp., Kyoto, Japan) equipped with a
LC-10 AD pump, SPD-10A UV–vis detector and LC-
Solution software. A C18 (Inertsil ODS 3 V) column
(250 × 4.6 mm i.d.; 5-μm particle size) was used for 2-
MQ analysis. The column was maintained at room
temperature. The mobile phase for the HPLC system con-
sisted of HPLC grade water (solvent A) and methanol
(solvent B) with a constant flow rate set at 1.2 mL/min. In
brief, aliquots of 10 μL were subjected to HPLC analysis.
An isocratic program was performed with 70 % solvent B
and 11-min running time per sample. The 2- and 5-MQ
was monitored at 315 nm. Peak integrality ratios of 2-MQ
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of MG was calculated by using the standard curve of 2-
MQ/5-MQ.The percentage of MG reduction was calcu-
lated using the equation below.
% Reduction ¼ Amount of MG in control −MG in test compoundð Þ
Amount of MG incontrol
 100
Statistical analysis
All data are presented as means ± SEM. In the experiment
of MG-derived AGEs, two-way ANOVA was evaluated for
the significant differences among groups. Other experi-
ments were analyzed the significant differences by one-
way ANOVA. Duncan’s post-hoc test was used to examine
differences among groups. A p-value < 0.05 was consid-
ered statistically significant.
Results
Effect of IFA on the formation of fluorescent MG-derived
AGEs and protein oxidation
Figure 1 depicts the fluorescence intensity of BSA incu-
bated with MG and IFA for up to 2 weeks. A 16- and
20-fold increase of fluorescence intensity, respectively,
was observed for BSA incubated with MG after 1 and
2 weeks. When IFA (1.25–5 mM) was incubated withFig. 1 Effect of IFA on fluorescent MG-derived AGEs at week 1 and 2. The
respectively. The results are presented as mean ± SEM (n = 3). ap <0.05 whe
BSA/MG at the same weekMG, the fluorescence intensity significantly decreased.
The inhibition by IFA (1.25–5 mM) ranged from 25.4 to
51.6 % at week 1 and from 27.5 to 54.9 % at week 2. In
addition, AG (1.25 mM) completely inhibited fluorescent
MG-derived AGEs. The level of Nε-CML and the con-
centration of protein carbonyl were determined at the
end of 2-weeks incubation (Table 1). The results demon-
strated that MG caused a 2-fold increase of Nε-CML for-
mation as compared to BSA controls. IFA (1.25–5 mM)
markedly reduced the formation of Nε-CML (29.9–
41.3 %, p <0.05 for all concentrations). A similar effect
was observed with 1.25 mM AG (37.0 % inhibition). The
protein carbonyl concentration in BSA incubated with
MG was 13.5-fold higher than that of BSA. AG sup-
pressed MG-induced carbonylation in BSA (78.3 %)
whereas IFA (5 mM) significantly (p <0.05) reduced the
elevated carbonyl content by a maximum of 52.3 %.
Effect of IFA on MG/lysine-induced DNA strand breakage
The effect of IFA on preventing DNA strand breakage is
presented in Fig. 2. Untreated plasmid and damaged
plasmid DNA were detected as major bands of super-
coiled (SC) and open circular (OC) forms, respectively.
Control experiments in which plasmid DNA was incu-
bated with lysine or MG or Cu2+ or IFA (0.1 and 1 mM)
alone had no significant effect on detection of the OCexcitation and emission wavelengths were at 355 and 460 nm,
n compared to BSA at the same week; bp <0.05 when compared to
Table 1 Effect of IFA on the formation of non-fluorescent Nε-CML
and carbonyl content in BSA incubated with MG at week 2
Experiments Nε-CML Carbonyl content
(ng/mL) (nmol/mg protain)
BSA 2.97 ± 0.21 0.14 ± 0.02
BSA / MG 5.75 ± 0.50a 1.89 ± 0.11a
BSA / MG / IFA (1.25 mM) 4.03 ± 0.44b 1.34 ± 0.40b
BSA / MG / IFA (2.5 mM) 3.93 ± 0.27b 0.97 ± 0.08b
BSA / MG / IFA (5 mM) 3.37 ± 0.44b 0.90 ± 0.11b
BSA / MG / AG (1.25 mM) 3.62 ± 0.40b 0.41 ± 0.08b
The results are presented as mean ± SEM (n = 3). ap <0.05 when compared to
BSA; bp <0.05 when compared to BSA/MG
Fig. 2 Effect of IFA on lysine/MG-induced DNA strand breakage in the abse
circular (OC) and supercoiled (SC) forms of plasmid DNA after pUC19 (0.25
50 mM MG, 300 μM CuSO4 or IFA (0.1 and 1 mM). (b) Lysine and MG in th
without addition of CuSO4. (c) Lysine and MG in the absence or presence o
The percentage of OC (% OC, see calculation method in Methods section)
expressing in (d) and (e) which represents data from gel (b) and (c), respec
compared to lysine/MG; bp <0.05 when compared to lysine/MG/Cu2+
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lysine and MG markedly induced DNA stand breakage
with 2-fold increase in the intensity of the OC band
(Fig. 2b). IFA significantly reduced DNA damage at
0.5 mM (23.0 %) and 1 mM (24.9 %) whereas IFA at
0.25 mM and 0.1 mM did not have a significant effect
(Fig. 2d). The cleavage of lysine/MG-treated DNA was
enhanced by addition of Cu2+ as shown by an increase
in the intensity of OC and a decrease in the intensity of
SC (Fig. 2c). In the presence of Cu2+, DNA strand break-
age was inhibited by IFA (0.1–1 mM) with percent in-
hibition values ranging from 24.0 to 57.0 % (Fig. 2e).nce or presence of Cu2+. Gel images express the intensity of open
μg) was incubated with the following treatments: (a) 50 mM lysine,
e absence or presence of various IFA concentrations (0.1–1 mM)
f various IFA concentrations (0.1–1 mM) co-incubating with CuSO4.
in each treatment was subtracted by % OC of untreated DNA before
tively. The results are presented as mean ± SEM (n = 3). ap <0.05 when
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superoxide anion and hydroxyl radical
To monitor the generation of superoxide anion induced
by the reaction between MG and lysine, the reduction of
cytochrome c was used as an indicator. Figure 3 repre-
sents a time-dependent increase of the reduced form of
cytochrome c, corresponding to increased superoxide
anion production during 180 min of incubation. Super-
oxide anion produced by the interaction of lysine with
MG created 13.8 nmol/mL reduced cytochrome c at
180 min (Table 2). The generation of superoxide anion
was suppressed by IFA after 10 min of incubation. At
the end of incubation, IFA (0.1–1 mM) inhibited lysine/
MG-induced superoxide anion production (5.0–25.0 %).
Table 2 shows the TBARS concentration in the MG-
lysine system indicating the generation of hydroxyl radi-
cals. Similar to the effect on superoxide anion formation,
IFA had the ability to reduce the generation of hydroxyl
radical. The percentage inhibition of hydroxyl radical
generation by IFA (0.1–1 mM) ranged from 26.1 to
44.6 %.
Effect of IFA on MG-trapping capacity
An evaluation of direct MG-trapping capacity was
carried out in order to investigate whether IFA could
directly scavenge MG. Fig. 4a and b demonstrate the
direct MG-trapping ability of IFA and AG after 1 h and
24 h of incubation. The level of 2-MQ, a product fromFig. 3 Effect of IFA on the production of superoxide anion in lysine/MG-ind
180 min. The results are presented as mean ± SEM (n = 3)the reaction of MG and o-PDA, represented free MG
remaining from the trapping reaction. The results
showed that AG exhibited MG-trapping ability with the
values of 82.9 % at 1 h and 93.5 % at 24 h. However, IFA
(1.25–5 mM) had no MG-trapping ability after 1 h and
24 h of incubation.
Discussion
The formation of AGEs is classified into three stages:
early, intermediate, and late [21]. The reaction between
protein and reducing sugars (glucose and fructose) re-
sults in Schiff base formation followed by rearrangement
to an Amadori product, referred to as the initial stage of
glycation. In the intermediate stage, reactive dicarbonyls,
particularly 3-deoxyglucosone and methylglyoxal are
generated from autoxidation of glucose and the degrad-
ation of Amadori products. In the late stage of glycation,
irreversible compounds called AGEs are formed through
various chemical reactions including direct degradation
of Amadori products or Schiff bases, protein modifica-
tion by dicarbonyl compounds and reactions between
Amadori products and AGE precursors. Methylglyoxal
(MG) is commonly recognized as the most reactive gly-
cating agent and irreversibly reacts with lysine residues
in proteins to form fluorescent crosslinking and non-
fluorescent crosslinking AGEs in the last stage of glyca-
tion [22, 23]. Our previous findings showed that IFA
prevented glucose- and fructose-induced formation ofuced glycation as measured by cytochrome c reduction within
Table 2 Effect of IFA on the production of superoxide anion
and hydroxyl radical in lysine/MG glycation at the time point of
180 min
Experiments Reduced cytochrome c TBARS
(nmol/mL) (nmol/mL)
Lysine / MG 13.79 ± 0.40 0.96 ± 0.03
Lysine / MG / IFA (0.1 mM) 13.10 ± 0.33 0.71 ± 0.03a
Lysine / MG / IFA (0.25 mM) 12.66 ± 0.41 0.58 ± 0.03a
Lysine / MG / IFA (0.5 mM) 11.88 ± 0.49a 0.56 ± 0.03a
Lysine / MG / IFA (1 mM) 10.34 ± 0.30a 0.53 ± 0.04a
The results are presented as mean ± SEM (n = 3). ap <0.05 when compared
to lysine/MG
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reduced conversion of the initial glycated product to
AGEs [18]. In the present study, MG-induced formation
of AGEs was also attenuated by IFA at the intermediate
stage of glycation. These findings, taken together, sug-
gest that IFA can protect from the initial and intermedi-
ate stages of glycation, thus leading to inhibition of the
formation of AGEs in the late stage.
Several lines of evidence show that superoxide and hy-
droxyl radicals can be generated from the reaction be-
tween lysine and MG [7]. It has been reported that MG-
induced albumin modification generates the cross-linked
methylglyoxal dialkylimine radical cation and the enediolFig. 4 The HPLC chromatogram of MG after reaction with IFA or AG at 1 h
derivatization using o-phenylenediamine at 315 nm. 5-methylquinoxaline (5radical anion of methylglyoxal during the glycation
process [24, 25]. The formation of these intermediates
leads to protein cross-linking and formation of radical
cation sites on the cross-linked proteins. The presence
of trace metal ions (copper and iron ions) enhances hy-
droxyl radical generation by reacting with hydrogen per-
oxide (H2O2) through the Fenton reaction [7]. ROS
generated from this reaction contributes oxidative modi-
fication of protein and DNA [7]. In the present study,
evidence of ROS-induced oxidative modifications in-
cluded the significant increase of protein carbonyl in
BSA as well as DNA damage. In addition, the formation
of superoxide anion and hydroxyl radicals generated
from lysine and MG was confirmed by the observed in-
crease in reduced cytochrome c and TBARS, which was
consistent with previous studies [7, 25]. However, when
the MG and lysine was incubated with IFA, the in-
creased cytochrome c reduction and TBARS level was
attenuated suggesting that IFA scavenges ROS. Consid-
erable interest has been devoted to phytochemical
compounds due to their ability to prevent lysine/MG-in-
duced protein glycation and DNA damage by acting as
free radical scavengers [26] and, our present findings in-
dicate that IFA also acts in this manner. Other mecha-
nisms related to the ability to trap MG have been
proposed [27, 28] but these results clearly demonstrated
that IFA did not directly react with MG, suggesting that(a) and 24 h (b). MG was detected as 2-methylquinoxaline (2-MQ) after
-MQ) was used as the internal standard
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mechanism of IFA. Further experiments are required to
investigate the effect of IFA on MG-induced cell toxicity.
Conclusion
The results suggest that the mechanism of IFA for the
inhibition of MG-induced protein glycation and DNA
damage is free radical scavenging of superoxide anion
and hydroxyl radical activity without the MG-trapping
ability.
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